欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号IS/H/0608/001
药品名称Alized
活性成分
    • Mirabegron 50.0 mg
剂型Prolonged-release tablet
上市许可持有人Adalvo Limited Malta Life Sciences Park Building 1 Level 4 Sir Temi Zammit Buildings San Gwann Industrial Estate San Gwann SGN 3000 Malta
参考成员国 - 产品名称Iceland (IS)
Alized
互认成员国 - 产品名称
    • Ireland (IE)
    • Austria (AT)
    • Spain (ES)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Germany (DE)
      Alized 50 mg Retardtabletten
    • Hungary (HU)
      Alized 50 mg retard tabletta
    • Denmark (DK)
      Mirabegron Stada
    • Czechia (CZ)
      Alized 50 mg
    • Belgium (BE)
      Mirabegron EG 50 mg tabletten met verlengde afgifte
    • Slovakia (SK)
    • Netherlands (NL)
    • Malta (MT)
    • Luxembourg (LU)
许可日期2024/07/24
最近更新日期2024/12/07
药物ATC编码
    • G04BD12 mirabegron
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase